Poly-γ-glutamic acid-based GGT-targeting and surface camouflage strategy for improving cervical cancer gene therapy

2017 ◽  
Vol 5 (6) ◽  
pp. 1315-1327 ◽  
Author(s):  
Jiao Tan ◽  
Huiyuan Wang ◽  
Fan Xu ◽  
Yingzhi Chen ◽  
Meng Zhang ◽  
...  
Keyword(s):  
Cervical Cancer ◽  
Gene Therapy ◽  
Gene Delivery ◽  
Glutamic Acid ◽  
Self Assembly ◽  
Cancer Gene Therapy ◽  
Layer By Layer ◽  
Cancer Gene ◽  
Gene Delivery System ◽  
System P

A γ-PGA-based GGT-targeting and surface camouflage strategy for constructing a ternary layer-by-layer self-assembly gene delivery system.

A novel receptor-targeted gene delivery system for cancer gene therapy

1999 ◽  
Vol 42 (2) ◽  
pp. 216-224 ◽  
Author(s):  
Peikun Tian ◽  
Shengjun Ren ◽  
Changchun Ren ◽  
Qingshan Teng ◽  
Shumin Qu ◽  
...  
Keyword(s):  
Gene Therapy ◽  
Gene Delivery ◽  
Delivery System ◽  
Cancer Gene Therapy ◽  
Cancer Gene ◽  
Gene Delivery System ◽  
Targeted Gene Delivery

scholarly journals Light-induced adenovirus gene transfer, an efficient and specific gene delivery technology for cancer gene therapy

2002 ◽  
Vol 9 (4) ◽  
pp. 365-371 ◽  
Author(s):  
Anders Høgset ◽  
Birgit Øvstebø Engesæter ◽  
Lina Prasmickaite ◽  
Kristian Berg ◽  
Øystein Fodstad ◽  
...  
Keyword(s):  
Gene Therapy ◽  
Gene Transfer ◽  
Gene Delivery ◽  
Cancer Gene Therapy ◽  
Specific Gene ◽  
Cancer Gene ◽  
Delivery Technology

Diffusible VP22-E2 Protein Kills Bystander Cells and Offers a Route for Cervical Cancer Gene Therapy

2005 ◽  
Vol 0 (0) ◽  
pp. 060123080936012
Author(s):  
Katie L. Green ◽  
Tom D. Southgate ◽  
Kate Mulryan ◽  
Lez J. Fairbairn ◽  
Peter L. Stern ◽  
...  
Keyword(s):  
Cervical Cancer ◽  
Gene Therapy ◽  
Cancer Gene Therapy ◽  
Cancer Gene ◽  
E2 Protein ◽  
Bystander Cells

scholarly journals Transcriptional Targeting in Cancer Gene Therapy

2003 ◽  
Vol 2003 (2) ◽  
pp. 110-137 ◽  
Author(s):  
Tracy Robson ◽  
David G. Hirst
Keyword(s):  
Gene Therapy ◽  
Gene Delivery ◽  
Cancer Gene Therapy ◽  
Cancer Gene ◽  
Cancer Treatments ◽  
Transcriptional Targeting ◽  
Exogenous Agents ◽  
Therapeutic Research ◽  
Systemic Gene Delivery ◽  
Near Future

Cancer gene therapy has been one of the most exciting areas of therapeutic research in the past decade. In this review, we discuss strategies to restrict transcription of transgenes to tumour cells. A range of promoters which are tissue-specific, tumour-specific, or inducible by exogenous agents are presented. Transcriptional targeting should prevent normal tissue toxicities associated with other cancer treatments, such as radiation and chemotherapy. In addition, the specificity of these strategies should provide improved targeting of metastatic tumours following systemic gene delivery. Rapid progress in the ability to specifically control transgenes will allow systemic gene delivery for cancer therapy to become a real possibility in the near future.

Pancreatic cancer: gene therapy approaches and gene delivery systems

2009 ◽  
Vol 10 (1) ◽  
pp. 73-88 ◽  
Author(s):  
Jin Xu ◽  
Chen Jin ◽  
Sijie Hao ◽  
Guopei Luo ◽  
Deliang Fu
Keyword(s):  
Pancreatic Cancer ◽  
Gene Therapy ◽  
Gene Delivery ◽  
Cancer Gene Therapy ◽  
Delivery Systems ◽  
Cancer Gene

Viral and Nonviral Gene Delivery Vectors for Cancer Gene Therapy

1998 ◽  
Vol 22 (5) ◽  
pp. 445-454 ◽  
Author(s):  
Richard J. Cristiano ◽  
Bo Xu ◽  
Dao Nguyen ◽  
Guido Schumacher ◽  
Masafumi Kataoka ◽  
...  
Keyword(s):  
Gene Therapy ◽  
Gene Delivery ◽  
Cancer Gene Therapy ◽  
Nonviral Gene Delivery ◽  
Cancer Gene ◽  
Gene Delivery Vectors
Sign in / Sign up

Export Citation Format

Share Document